Last quarter (Q3 2022), Humanigen's total revenue was $221.00K, a decrease of -78.67% from the same quarter last year. In Q3, Humanigen's net income was $-23.69M. See Humanigen’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 21	Dec 20	Dec 19	Dec 18	Dec 17
Total Revenue	$ 3.33M	$ 3.60M	$ 312.00K	$ 0.00	$ 0.00	$ 0.00
Cost of Revenue	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-
Operating Expense	$ 108.28M	$ 236.37M	$ 88.51M	$ 8.94M	$ 11.33M	$ 19.03M
Operating Income	$ -104.95M	$ -232.77M	$ -88.20M	$ -8.94M	$ -11.33M	$ -19.03M
Net Non Operating Interest Income Expense	$ -3.55M	$ -2.26M	$ -1.34M	$ -1.35M	$ -852.00K	$ -3.06M
Other Income Expense	$ -166.00K	$ -1.61M	$ -1.00K	$ -1.00K	$ 179.00K	$ 100.00K
Pretax Income	$ -108.66M	$ -236.65M	$ -89.53M	$ -10.29M	$ -12.00M	$ -21.99M
Tax Provision	-	-	-	-	-	-
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	$ -108.66M	$ -236.65M	$ -89.53M	$ -10.29M	$ -12.00M	$ -21.99M
Basic EPS	$ -1.46	$ -4.04	$ -2.42	$ -0.45	$ -0.65	$ -7.35
Diluted EPS	$ -1.46	$ -4.04	$ -2.42	$ -0.45	$ -0.65	$ -7.35
Basic Average Shares	$ 300.83M	$ 58.53M	$ 36.96M	$ 22.36M	$ 18.95M	$ 3.00M
Diluted Average Shares	$ 300.83M	$ 58.53M	$ 36.96M	$ 22.36M	$ 18.95M	$ 3.00M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 108.28M	$ 236.37M	$ 88.51M	$ 8.94M	$ 11.33M	$ 19.03M
Net Income From Continuing And Discontinued Operation	$ -108.66M	$ -236.65M	$ -89.53M	$ -10.29M	$ -12.00M	$ -21.99M
Normalized Income	$ -108.66M	$ -236.65M	$ -89.53M	$ -10.29M	$ -11.86M	$ -21.66M
Interest Expense	$ 3.55M	$ 2.26M	$ 1.34M	$ 1.35M	$ 852.00K	$ 3.06M
EBIT	$ -105.11M	$ -234.38M	$ -88.20M	$ -8.95M	$ -11.15M	$ -18.93M
EBITDA	$ -105.11M	$ -234.38M	$ -88.20M	$ -8.95M	$ -11.13M	$ -18.88M

Currency in USD

Humanigen Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing